Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment begins in first-in-human study of REGN-5459

Oct. 14, 2019

Metformin rejuvenates stem cells, restores CNS remyelination

Oct. 14, 2019

Aruna Bio receives support for preclinical development of AB-126

Oct. 11, 2019

PanOptica reports phase I/II topline data on PAN-90806 for wet AMD

Oct. 11, 2019

Aerpio releases phase Ib interim data on topical ocular formulation of AKB-9778

Oct. 11, 2019

OSE Immunotherapeutics' bispecific anti-PD-1/IL-7 fusion molecule tested in vitro and in vivo

Oct. 11, 2019

Kangpu completes first-in-human study of KPG-818

Oct. 11, 2019

MGB Biopharma completes first cohort in phase IIa study of MGB-BP-3 in CDAD

Oct. 11, 2019

NIH gives grant to Oligomerix to develop inhibitors of tau olgomer formation

Oct. 11, 2019

Potent new small-molecule inhibitors block apoptosis in mice

Oct. 11, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...